Abvision Inc. is a biopharmaceutical company with its headquarters in Reno Nevada and a R&D facility in San Jose California. The company focuses on developing therapeutics for cancers and infection diseases. Abvision has successfully established emerging platforms of several therapeutic modalities for therapeutic antibody, vaccine and cell therapy.

Using our proprietary technology platforms, Abvision has built a sustainable and competitive drug pipelines for the next generation of medicine in various therapeutic areas. Our R&D effort focuses on the pre-clinical stage of drug discovery and subsequently seeks for strategic partnership for further clinical development and commercialization. We are open to opportunities worldwide for co-developing or out-licensing our pre-clinical drug products as well as technology platforms at various developmental stages.